Crossmark

Oral L-ergothioneine supplementation in women with suboptimal ovarian reserve: a single-center, open-label, self-controlled pilot study of ovarian reserve markers, endocrine profiles, and reproductive aging-related symptoms

Crossref DOI link: https://doi.org/10.1186/s12905-026-04604-x

Published Online: 2026-06-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Wei

Guo, Cong

Ding, Wei

Cao, Juan

Ju, Hongying

Liu, Fengjuan

Xiao, Guohua
License Information

Text and Data Mining valid from 2026-06-17

Accepted Manuscript valid from 2026-06-17
More Information

Article History

Received: 28 April 2026

Accepted: 5 June 2026

First Online: 17 June 2026

Declarations

:

: This study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice (GCP) guidelines. The study protocol was formally approved by the Institutional Ethics Committee of Qingdao Central Hospital (Approval No.: SY202502202). Written informed consent to participate was obtained from all participants prior to screening.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below